Log in or Sign up for Free to view tailored content for your specialty!
Gynecologic Cancer News
ASCO members urged to help support cancer care in Ukraine, host countries
As important as the care of Ukrainian citizens with cancer is to clinicians in that country, this priority has been overshadowed by more immediate concerns.
Age at diagnosis and cancer subtype may affect risk for CV death among cancer survivors
Among survivors of nine common cancers, risk for CV death overtook cancer mortality for most cancer subtypes among patients aged at least 80 years, researchers reported.
Log in or Sign up for Free to view tailored content for your specialty!
‘Like’ it or not: The dos and don’ts of social media for oncologists
Just as physicians became accustomed to wearing pagers 40 years ago or being tied to smartphones 2 decades ago, many have become active on social media as it entered their practices.
In age of misinformation, cancer care community seeks new ways to improve communication
An important component of cancer care is communication with patients and caregivers about their disease.
32% of older women who survived certain cancers report lower extremity lymphedema
Nearly one-third of older women who survived colorectal, endometrial or ovarian cancer reported lower extremity lymphedema, according to data published in JAMA Network Open.
New cancer diagnosis associated with risk for fatal, nonfatal cardiovascular events
New cancer diagnosis appeared associated with increased risk for cardiovascular death, as well as incident heart failure, stroke or pulmonary embolism, according to a retrospective cohort study published in JACC: CardioOncology.
Obesity, central adiposity may increase risk for future cancers
Obesity and elevated central adiposity were associated with increased risk for future cancers, including gastrointestinal and gynecologic cancer, researchers reported.
Only 14% of new cancer drug approvals displace existing standards of care
Most cancer drug approvals between 2016 and 2021 applied to second-, third- or later-line treatment settings and did not displace current standard-of-care therapies, according to a study published in JAMA Network Open.
Collaboration aims to develop nanoparticle for cancer treatment
In a research collaboration with Mayo Clinic, nanomedical company NaNotics LLC plans to develop and assess a novel subtractive nanoparticle for use in cancer treatment.
Hyperthermic intraperitoneal chemotherapy may benefit some women with ovarian cancer
Adding hyperthermic intraperitoneal chemotherapy to cytoreductive surgery did not significantly prolong PFS or OS among women with advanced epithelial ovarian cancer, according to a single-blind, randomized study in JAMA Surgery.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read